C12Y 304/14005
Dipeptidyl-peptidase iv
Official title: Dipeptidyl-peptidase IV (3.4.14.5)
C12Y304/14005 (Dipeptidyl-peptidase iv) appears on 42 US grants and 89 published applications in this corpus.
Search patents in C12Y- Granted patents
- 42
- Published applications
- 89
- Assignees
- 56
- Inventors
- 210
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 7 |
| 2004 | 3 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 1 | 4 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 4 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 3 |
| 2014 | 0 | 5 |
| 2015 | 1 | 6 |
| 2016 | 6 | 6 |
| 2017 | 4 | 8 |
| 2018 | 0 | 3 |
| 2019 | 2 | 4 |
| 2020 | 3 | 3 |
| 2021 | 2 | 4 |
| 2022 | 0 | 5 |
| 2023 | 1 | 6 |
| 2024 | 1 | 9 |
| 2025 | 4 | 2 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Multispecific proteins17 Jun 2025US 12,331,090 B2Molecular Partners AG
- Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof22 Apr 2025US 12,281,170 B2StarkAge Therapeutics
- Humanized dipeptidyl-peptidase IV (DPP4) animals25 Mar 2025US 12,256,720 B2Regeneron Pharmaceuticals, Inc.
- Bispecific antibodies specific for OX404 Mar 2025US 12,240,911 B2Hoffmann-La Roche Inc.
- Conjugate vaccine targeting a disease-causing biological protein27 Aug 2024US 12,070,498 B2Funpep Co., Ltd.
- Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof13 Aug 2026US 2026/0234284 A1StarkAge Therapeutics
- Treatment for ovarian cancer with oligonucleotides targeting fibroblast activation protein alpha5 Mar 2026US 2026/0062705 A1
- Tetravalent multispecific antibodies19 Feb 2026US 2026/0049160 A1Hoffmann-La Roche Inc.
- Fusion protein comprising light protein and anti-fap antibody and uses thereof4 Dec 2025US 2025/0368754 A1Kanaph Therapeutics Inc.
- Fluorescent Probe for Detecting Peptide Bond Hydrolase9 Oct 2025US 2025/0313879 A1Riken
Most cited
By later US patents
- Compositions and methods relating to reduction of symptoms of autism63US 6,899,876 B2Prothera, Inc. · 2005
- Compositions and methods relating to reduction of symptoms of autism62US 6,821,514 B2Prothera, Inc. · 2004
- Compositions and methods relating to reduction of symptoms of autism57US 6,808,708 B2Prothera, Inc. · 2004
- Enzyme treatment of foodstuffs for Celiac Sprue47US 7,303,871 B2The Board of Trustees of the Leland Stanford Junior University · 2007
- Compositions and methods for inhibition of cancer invasion and angiogenesis41US 6,573,096 B1The Research Foundation at State University of New York · 2003